Baudax Bio to Present at Oppenheimer Fall Healthcare Life Sciences & Medtech Summit
September 18 2020 - 7:35AM
Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on
therapeutics for acute care settings, today announced Gerri
Henwood, the Company’s President and Chief Executive Officer, will
present at the Oppenheimer Fall Healthcare Life Sciences &
Medtech Summit on Tuesday, September 22, 2020 at 3:20 p.m. ET.
A live webcast of the presentation will be
available on the “Presentations” page within the Investors section
of the Baudax Bio website at
https://www.baudaxbio.com/news-and-investors. A replay will be
available on the Baudax Bio website for a period of 30 days
following the event.
About Baudax Bio
Baudax Bio is a pharmaceutical company focused
on therapeutics for acute care settings. The launch of the
Company’s first commercial product, ANJESO®, began in June of 2020.
Baudax’s New Drug Application for ANJESO was approved by FDA on
February 20, 2020 for the management the management of moderate to
severe pain, alone or in combination with other non-NSAID
analgesics. ANJESO is a once daily IV NSAID with preferential Cox-2
activity, which has successfully completed three Phase III clinical
trials, including two pivotal efficacy trials, a large double-blind
Phase III safety trial and other studies for the management of
moderate to severe pain. As a non-opioid, IV meloxicam has the
potential to overcome many of the issues associated with commonly
prescribed opioid therapeutics, including respiratory depression,
constipation, excessive nausea and vomiting, as well as having no
addictive potential while maintaining meaningful analgesic effects
for relief of pain. For more information please
visit www.baudaxbio.com.
CONTACT:
Investor Relations Contact:Argot PartnersSam
Martin / Claudia Styslinger(212)
600-1902sam@argotpartners.comclaudia@argotpartners.com
Baudax Bio, Inc.Ryan D. Lake(484)
395-2436rlake@baudaxbio.com
Media Contact:Argot PartnersDavid Rosen(212)
600-1902david.rosen@argotpartners.com
Baudax Bio (NASDAQ:BXRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Baudax Bio (NASDAQ:BXRX)
Historical Stock Chart
From Apr 2023 to Apr 2024